Pre-treatment haemoglobin and peripheral blood lymphocyte count as independent predictors of outcome in carcinoma of cervix

PJ Hoskin, AM Rojas, SN Peiris, V Mullassery… - Clinical Oncology, 2014 - Elsevier
Aims To evaluate pre-treatment haemoglobin and peripheral blood lymphocyte (PBL) counts
as predictors of treatment outcome in cervix carcinoma treated with radical chemoradiation …

Identification of genes associated with progression and metastasis of advanced cervical cancers after radiotherapy by cDNA microarray analysis

Y Harima, K Ikeda, K Utsunomiya, T Shiga… - International Journal of …, 2009 - Elsevier
PURPOSE: To identify a set of genes related to the progression and metastasis of advanced
cervical cancer after radiotherapy and to establish a predictive method. METHODS AND …

[HTML][HTML] Clinical implication of surgically treated early-stage cervical cancer with multiple high-risk factors

K Matsuo, S Mabuchi, M Okazawa… - Journal of …, 2015 - ncbi.nlm.nih.gov
Objective Presence of high-risk factor in cervical cancer is known to be associated with
decreased survival outcomes. However, the significance of multiple high-risk factors in early …

Lymphocyte radiosensitivity is a significant prognostic factor for morbidity in carcinoma of the cervix

CML West, SE Davidson, SAG Elyan… - International Journal of …, 2001 - Elsevier
Purpose: To study the relationship between pretreatment peripheral blood lymphocyte
radiosensitivity and morbidity following radiation therapy. Methods and Materials: A …

Immunohistochemical prediction of radiation response and local control in radiation therapy for cervical cancer.

T Nakano, K Oka, A Ishikawa… - Cancer detection and …, 1998 - europepmc.org
Prognosis of 64 cervical cancer patients treated with radiation therapy was analyzed by
tumor expressions of c-erbB-2 oncoprotein (CerbB-OPE) and p53 protein (p53-PE), Ki-67 …

Comparison of clinical outcomes of squamous cell carcinoma, adenocarcinoma, and adenosquamous carcinoma of the uterine cervix after definitive radiotherapy: a …

J Zhou, SG Wu, JY Sun, FY Li, HX Lin, QH Chen… - Journal of cancer …, 2017 - Springer
Purpose To evaluate the clinical outcomes in patients with International Federation of
Gynecology and Obstetrics (FIGO) stage I to IVA squamous cell carcinoma (SCC) …

Low ERCC1 mRNA and protein expression are associated with worse survival in cervical cancer patients treated with radiation alone

CM Doll, M Prystajecky, M Eliasziw… - Radiotherapy and …, 2010 - Elsevier
PURPOSE: To evaluate the association of excision repair cross-complementation group 1
(ERCC1) expression, using both mRNA and protein expression analysis, with clinical …

Cyclooxygenase-2 (COX-2) expression in locally advanced cervical cancer patients undergoing chemoradiation plus surgery

G Ferrandina, FO Ranelletti, F Legge, L Lauriola… - International Journal of …, 2003 - Elsevier
Purpose: To investigate whether cyclooxygenase-2 (COX-2) could be a marker of clinical
outcome in cervical cancer patients undergoing concomitant chemoradiation plus surgery …

Tissue biomarkers as prognostic variables of cervical cancer

A Gadducci, ME Guerrieri, C Greco - Critical reviews in oncology …, 2013 - Elsevier
The most important prognostic variables of cervical carcinoma are FIGO stage, lymph node
status and clinical-pathological features of primary tumor. Recently, there has been …

Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma

EL Levine, A Renehan, R Gossiel, SE Davidson… - Radiotherapy and …, 1995 - Elsevier
Apoptosis is an important mechanism of cell death in tumours and it is seen both prior to and
following radiotherapy. In this study patients with proven carcinoma of the cervix had …